Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.66 USD
Change Today -0.12 / -6.74%
Volume 64.6K
FHCO On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ CM
As of 8:10 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

female health company (FHCO) Snapshot

Open
$1.78
Previous Close
$1.78
Day High
$1.79
Day Low
$1.65
52 Week High
10/17/14 - $4.70
52 Week Low
07/21/15 - $1.38
Market Cap
47.7M
Average Volume 10 Days
144.4K
EPS TTM
$0.12
Shares Outstanding
28.8M
EX-Date
07/14/14
P/E TM
14.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for FEMALE HEALTH COMPANY (FHCO)

female health company (FHCO) Related Bloomberg News

View More Bloomberg News

female health company (FHCO) Related Businessweek News

No Related Businessweek News Found

female health company (FHCO) Details

The Female Health Company develops, manufactures, and markets consumer health care products. It offers the FC2 female condom that provides women dual protection against unintended pregnancy and sexually transmitted infections, including HIV/AIDS. The company sells its products to global agencies, non-government organizations, ministries of health, and other government agencies directly, as well as through distribution agreements and other arrangements with commercial partners. It operates in South Africa, Angola, Brazil, Uganda, Nigeria, Zimbabwe, Tanzania, the United States, Brazil, Malaysia, the Democratic Republic of the Congo, and internationally. The company was founded in 1896 and is headquartered in Chicago, Illinois.

149 Employees
Last Reported Date: 12/2/14
Founded in 1896

female health company (FHCO) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $50.7K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $207.5K
Executive Vice President of Sales and Marketi...
Total Annual Compensation: $101.4K
Compensation as of Fiscal Year 2014.

female health company (FHCO) Key Developments

The Female Health Company Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015

The Female Health Company reported unaudited consolidated earnings results for the third quarter and nine months ended June 30, 2015. The company generated net revenues of $7,813,207 and net income of $1,170,974, or $0.04 per diluted share, for the three months ended June 30, 2015, compared with net revenues of $7,900,055 and net income of $1,159,498, or $0.04 per diluted share, for the three months ended June 30, 2014. Net revenues decreased $86,848, or 1%, on a 5% increase in unit sales, for the three months ended June 30, 2015, when compared with the same period last year. Operating income for the quarter ended June 30, 2015 totaled $1,453,848, versus operating income of $2,027,630 in the third quarter of the fiscal year 2014, a decrease of 28%. The decrease was primarily due to higher operating expenses, partially offset by improved gross profit margins. The Company's net income increased $11,476, or 1%, to $1,170,974 in the three months ended June 30, 2015, versus net income of $1,159,498 in the same period of the prior year. Net income approximated 15% of net revenues for the third quarters of both the fiscal year 2015 and the fiscal year 2014. Adjusted EBITDA totaled $1,739,360 in the third quarter of the fiscal year 2015, compared with adjusted EBITDA of $2,363,945 in the same period last year. Adjusted diluted EBITDA per share of $0.06 in the third quarter of the current fiscal year compared with $0.08 in the third quarter of the fiscal year 2014. Income before income taxes was $1,455,874 against $2,010,819 a year ago. The company generated net revenues of $25,449,880 and net income of $3,643,465, or $0.13 per diluted share, for the nine months ended June 30, 2015, compared with net revenues of $18,936,473 and net income of $2,999,182, or $0.10 per diluted share, for the nine months ended June 30, 2014. Operating income for the nine months ended June 30, 2015 increased $1,450,601, or 33%, to $5,857,090, versus operating income of $4,406,489 in the same period of the fiscal year 2014. The increase resulted from higher net revenue and improved gross margins, partially offset by higher operating expenses. The company's net income increased $644,283, or 21%, to $3,643,465 in the nine months ended June 30, 2015, versus net income of $2,999,182 in the same period of the previous fiscal year. Net income per diluted share increased 30% to $0.13 during the first nine months of the fiscal year 2015, compared with $0.10 in the prior-year period. Adjusted EBITDA improved to $6,817,876 in the nine months ended June 30, 2015, compared with adjusted EBITDA of $5,496,265 in the same period last year. Adjusted diluted EBITDA per share increased 26% to $0.24 in the nine months ended June 30, 2015, compared with $0.19 in the same period last year. Income before income taxes was $5,905,240 against $4,454,276 a year ago. Net cash used in operating activities was $3,037,621 against net cash provided by operating activities of $1,481,072 a year ago.

The Female Health Company Announces Management Changes

The Female Health Company announced that Karen King, the company's president and chief executive officer, has left the company to pursue other interests. The company's chairman and former president and CEO, O.B. Parrish, has been reappointed by the board to serve as CEO.

The Female Health Company Announces Sales Guidance for the Third Quarter of Fiscal 2015

The Female Health Company announced that it expects to report unit sales for the third quarter of fiscal 2015 totaling approximately 14.4 million units. This achievement represents an increase of approximately 5% relative to the corresponding period of the previous fiscal year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FHCO:US $1.66 USD -0.12

FHCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FHCO.
View Industry Companies
 

Industry Analysis

FHCO

Industry Average

Valuation FHCO Industry Range
Price/Earnings 16.6x
Price/Sales 1.6x
Price/Book 1.6x
Price/Cash Flow 16.6x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FEMALE HEALTH COMPANY, please visit www.femalehealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.